Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Adding Parnate and prazosin.

Posted by ed_uk2010 on March 11, 2012, at 13:39:44

In reply to Re: Adding Parnate and prazosin. ed_uk2010, posted by SLS on March 11, 2012, at 7:48:16

Gosh Scott, that abstract is a bit beyond me!

> Hi Ed.
>
> I found this. I believe it lends evidence to my pet theory that the neural hyperactivity of the sgACC seen in depression is reduced by prazosin via NE alpha-1b receptor blockade.
>
>
> http://www.ncbi.nlm.nih.gov/pubmed/18704022
>
>
> CNS Spectr. 2008 Aug;13(8):663-81.
> The subgenual anterior cingulate cortex in mood disorders.
> Drevets WC, Savitz J, Trimble M.
> Source
>
> Section on Neuroimaging in Mood and Anxiety Disorders, Molecular Imaging Branch, National Institute of Mental Health, Bethesda, MD, USA. drevetsw@mail.nih.gov
> Abstract
>
> The anterior cingulate cortex (ACC) ventral to the genu of the corpus callosum has been implicated in the modulation of emotional behavior on the basis of neuroimaging studies in humans and lesion analyses in experimental animals. In a combined positron emission tomography/magnetic resonance imaging study of mood disorders, we demonstrated that the mean gray matter volume of this "subgenual" ACC (sgACC) cortex is abnormally reduced in subjects with major depressive disorder (MDD) and bipolar disorder, irrespective of mood state. Neuropathological assessments of sgACC tissue acquired postmortem from subjects with MDD or bipolar disorder confirmed the decrement in gray matter volume, and revealed that this abnormality was associated with a reduction in glia, with no equivalent loss of neurons. In positron emission tomography studies, the metabolic activity was elevated in this region in the depressed relative to the remitted phases of the same MDD subjects, and effective antidepressant treatment was associated with a reduction in sgACC activity. Other laboratories replicated and extended these findings, and the clinical importance of this treatment effect was underscored by a study showing that deep brain stimulation of the sgACC ameliorates depressive symptoms in treatment-resistant MDD. This article discusses the functional significance of these findings within the context of the preclinical literature that implicates the putative homologue of this region in the regulation of emotional behavior and stress response. In experimental animals, this region participates in an extended "visceromotor network" of structures that modulates autonomic/neuroendocrine responses and neurotransmitter transmission during the neural processing of reward, fear, and stress. These data thus hold important implications for the development of neural models of depression that can account for the abnormal motivational, neuroendocrine, autonomic, and emotional manifestations evident in human mood disorders.
>
> PMID:
> 18704022
> [PubMed - indexed for MEDLINE]
> PMCID:
> PMC2729429
>
> Free PMC Article

 

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:ed_uk2010 thread:1005781
URL: http://www.dr-bob.org/babble/20120302/msgs/1012803.html